-
-
-
-
-
-
-
Immunogen (IMGN) Tops Q2 EPS by 11c
-
-
-
-
-
-
-
Immunogen (IMGN) Misses Q2 EPS by 3c
-
-
-
-
-
-
-
Immunogen (IMGN) Announces In-Line Q3 EPS, Reports $245.8M of Cash and Cash Equivalents
-
-
-
-
-
-
-
ImmunoGen Reports Recent Progress and 2020 Financial Results
-
-
-
-
-
-
-
ImmunoGen Reports Recent Progress and First Quarter 2020 Financial Results
-
-
-
-
-
-
-
ImmunoGen Reports Recent Progress and Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
Immunogen (IMGN) Reports In-Line Q3 EPS, Revenues Miss; Offers FY18 Revenue Outlook Below Consensus
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

